| Cidara Therapeutics Inc | — | 85.1K | $18.8M | 10.1% | — | Held |
| Terns Pharmaceuticals Inc | — | 443.8K | $17.9M | 9.6% | — | Held |
| UroGen Pharma Ltd. | URGN | 718.4K | $16.8M | 9.0% | — | Held |
| Cogent Biosciences, Inc. | COGT | 366.2K | $13M | 7.0% | — | Held |
| Dynavax Technologies Corp | — | 525.6K | $8.08M | 4.3% | — | Held |
| Sionna Therapeutics, Inc. | SION | 180.6K | $7.43M | 4.0% | — | Held |
| Immunovant, Inc. | IMVT | 288.7K | $7.34M | 3.9% | — | Held |
| Axsome Therapeutics, Inc. | AXSM | 37.4K | $6.84M | 3.7% | — | Held |
| Savara Inc | SVRA | 995.4K | $6M | 3.2% | — | Held |
| Mind Medicine Mindmed Inc | — | 425.2K | $5.69M | 3.0% | — | Held |
| Taysha Gene Therapies, Inc. | TSHA | 980.8K | $5.39M | 2.9% | — | Held |
| Ocular Therapeutix, Inc | OCUL | 418.1K | $5.08M | 2.7% | — | Held |
| Amicus Therapeutics Inc | — | 352.9K | $5.03M | 2.7% | — | Held |
| Cabaletta Bio, Inc. | CABA | 2.25M | $4.94M | 2.6% | — | Held |
| United Therapeutics Corp Del | — | 9.45K | $4.61M | 2.5% | — | Held |
| Revolution Medicines Inc | — | 54.9K | $4.37M | 2.3% | — | Held |
| Belite Bio, Inc | BLTE | 24.7K | $3.95M | 2.1% | — | Held |
| Bright Minds Biosciences Inc. | DRUG | 47.3K | $3.69M | 2.0% | — | Held |
| Zai Lab Ltd | ZLAB | 196.9K | $3.47M | 1.9% | — | Held |
| Zenas BioPharma, Inc. | ZBIO | 83.4K | $3.03M | 1.6% | — | Held |
| Quince Therapeutics, Inc. | QNCX | 858.7K | $2.88M | 1.5% | — | Held |
| Avalo Therapeutics, Inc. | AVTX | 153.3K | $2.78M | 1.5% | — | Held |
| Capricor Therapeutics, Inc. | CAPR | 96.3K | $2.78M | 1.5% | — | Held |
| Palvella Therapeutics Inc Ne | — | 25.5K | $2.67M | 1.4% | — | Held |
| Celldex Therapeutics Inc New | — | 88.3K | $2.4M | 1.3% | — | Held |
| Assembly Biosciences, Inc. | ASMB | 65.3K | $2.22M | 1.2% | — | Held |
| Oric Pharmaceuticals, Inc. | ORIC | 255.4K | $2.09M | 1.1% | — | Held |
| Protara Therapeutics, Inc. | TARA | 360K | $1.92M | 1.0% | — | Held |
| Trevi Therapeutics, Inc. | TRVI | 148.3K | $1.86M | 1.0% | — | Held |
| Tyra Biosciences, Inc. | TYRA | 58.7K | $1.54M | 0.8% | — | Held |
| Travere Therapeutics, Inc. | TVTX | 38K | $1.45M | 0.8% | — | Held |
| Viridian Therapeutics Inc | — | 43.2K | $1.35M | 0.7% | — | Held |
| Rezolute, Inc. | RZLT | 513.8K | $1.21M | 0.6% | — | Held |
| Dianthus Therapeutics Inc | — | 26.2K | $1.08M | 0.6% | — | Held |
| Spruce Biosciences, Inc. | SPRB | 12.1K | $1.06M | 0.6% | — | Held |
| Aardvark Therapeutics, Inc. | AARD | 69.5K | $912.1K | 0.5% | — | Held |
| Genmab A/S | — | 29.2K | $898.2K | 0.5% | — | Held |
| Palisade Bio, Inc. | PALI | 367.1K | $862.7K | 0.5% | — | Held |
| Fulcrum Therapeutics, Inc. | FULC | 72.1K | $815K | 0.4% | — | Held |
| Ultragenyx Pharmaceutical In | — | 31.7K | $730K | 0.4% | — | Held |
| Palatin Technologies Inc | PTN | 34K | $522.5K | 0.3% | — | Held |
| Inventiva Sa | — | 100K | $465K | 0.2% | — | Held |
| Century Therapeutics, Inc. | IPSC | 463K | $460.6K | 0.2% | — | Held |
| Biomea Fusion, Inc. | BMEA | 250K | $310K | 0.2% | — | Held |
| Entera Bio Ltd. | ENTX | 17.1K | $33.3K | 0.0% | — | Held |